Hims was founded in 2017 by Andrew Dudum and Jack Abraham. In an October 2020 press release, the company announced its plan to go public through a reverse merger with blank-check company Oaktree Acquisition Corp.
Hims is a telehealth service for men's wellness and care, providing treatment options for hair loss, ED & more. The company has raised nearly $200 million in Venture Capital funding from investors including DCM Ventures, Define Ventures, Material Companies, McKesson Ventures, Next Play Capital, NewView Capital, TriplePoint Venture Growth, Rx3 Ventures, 7 Global Capital, Maverick Ventures, IVP, Forerunner Ventures, and Thrive Capital. It has been widely reported that Hims last raised $100 million in February 2019 at a post-money valuation of $1 billion.
Hims is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Hims pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Hims is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.